Full-Time

Key Accounts Manager

Posted on 4/14/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Senior

Bengaluru, Karnataka, India

Candidate must be based in Karnataka and willing to travel extensively within the assigned territory.

Category
Strategic Account Management
Sales & Account Management
Required Skills
Marketing
Requirements
  • Education: B. Pharm / B.Sc. (Life Sciences) / MBA (preferred)
  • Experience: 7-8 years in pharmaceutical sales, with at least 2+ years in biologics, immunology, or gastroenterology.
  • Skills: Strong sales acumen, scientific knowledge, KOL engagement, negotiation skills, and strategic account management.
  • Other: Willingness to travel extensively within the assigned territory.
Responsibilities
  • Achieve sales targets for IBD biologics in the assigned territory.
  • Develop and execute strategic account plans to drive product penetration.
  • Identify and maximize business opportunities within hospitals, clinics, and specialty centers.
  • Build and maintain strong relationships with gastroenterologists, IBD specialists, immunologists.
  • Conduct scientific discussions, product detailing, and therapy presentations.
  • Partner with patient support programs and medical teams to enhance patient access.
  • Drive formulary inclusion and reimbursement discussions in key hospitals.
  • Stay updated on IBD treatment guidelines, biologics landscape, and competitor activity.
  • Organize and participate in CMEs, HCP training initiatives.
  • Educate HCPs on product differentiation, efficacy, and safety profiles.
  • Work closely with Marketing, Medical Affairs, and Market Access teams to develop tailored strategies.
  • Support patient access programs.
  • Maintain and update sales reports, including daily call reports, customer interactions, and business development activities.
  • Track and analyze territory performance, competitor insights, and market trends.
  • Provide regular business reviews, forecasting, and strategic recommendations to management.
  • Utilize CRM tools for tracking KOL engagements, sales progression, and account planning.
Desired Qualifications
  • MBA (preferred)

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to support its operations. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its work. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to innovate and provide life-changing treatments while also promoting a healthier planet.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.